吉利德科学：丑陋收益背后隐藏的强劲季度表现 (NASDAQ:GILD)
· seekingalpha.com
吉利德科学在 26 年第二季度后被上调至审慎的“买入”评级，这得益于强劲的营收增长和上调的业绩指引。点击此处了解更多关于 GILD 股票的信息。
Gilead Sciences, Inc. ( GILD ) is one of my long‑term holdings, and it actually took several years before this investment paid off. In the last few years, I w...